Epidemiologic Features of Recovery From SARS-CoV-2 Infection
JAMA Network Open · 2024
DOI: 10.1001/jamanetworkopen.2024.17440 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2024. Verfasst von Elizabeth C Oelsner und 44 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCRR NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Importance Persistent symptoms and disability following SARS-CoV-2 infection, known as post–COVID-19 condition or “long COVID,” are frequently reported and pose a substantial personal and societal burden.
Objective
To determine time to recovery following SARS-CoV-2 infection and identify factors associated with recovery by 90 days. Design, Setting, and Participants For this prospective cohort study, standardized ascertainment of SARS-CoV-2 infection was conducted starting in April 1, 2020, across 14 ongoing National Institutes of Health–funded cohorts that have enrolled and followed participants since 1971. This report includes data collected through February 28, 2023, on adults aged 18 years or older with self-reported SARS-CoV-2 infection. Exposure Preinfection health conditions and lifestyle factors assessed before and during the pandemic via prepandemic examinations and pandemic-era questionnaires. Main Outcomes and Measures Probability of nonrecovery by 90 days and restricted mean recovery times were estimated using Kaplan-Meier curves, and Cox proportional hazards regression was performed to assess multivariable-adjusted associations with recovery by 90 days.
Results
Of 4708 participants with self-reported SARS-CoV-2 infection (mean [SD] age, 61.3 [13.8] years; 2952 women [62.7%]), an estimated 22.5% (95% CI, 21.2%-23.7%) did not recover by 90 days post infection. Median (IQR) time to recovery was 20 (8-75) days. By 90 days post infection, there were significant differences in restricted mean recovery time according to sociodemographic, clinical, and lifestyle characteristics, particularly by acute infection severity (outpatient vs critical hospitalization, 32.9 days [95% CI, 31.9-33.9 days] vs 57.6 days [95% CI, 51.9-63.3 days]; log-rank P < .001). Recovery by 90 days post infection was associated with vaccination prior to infection (hazard ratio [HR], 1.30; 95% CI, 1.11-1.51) and infection during the sixth (Omicron variant) vs first wave (HR, 1.25; 95% CI, 1.06-1.49). These associations were mediated by reduced severity of acute infection (33.4% and 17.6%, respectively). Recovery was unfavorably associated with female sex (HR, 0.85; 95% CI, 0.79-0.92) and prepandemic clinical cardiovascular disease (HR, 0.84; 95% CI, 0.71-0.99). No significant multivariable-adjusted associations were observed for age, educational attainment, smoking history, obesity, diabetes, chronic kidney disease, asthma, chronic obstructive pulmonary disease, or elevated depressive symptoms. Results were similar for reinfections. Conclusions and Relevance In this cohort study, more than 1 in 5 adults did not recover within 3 months of SARS-CoV-2 infection. Recovery within 3 months was less likely in women and those with preexisting cardiovascular disease and more likely in those with COVID-19 vaccination or infection during the Omicron variant wave.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York.
- Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center, New York, New York.
- Center for Epidemiology and Population Health, Northwestern Feinberg School of Medicine, Chicago, Illinois.
- Department of Epidemiology, School of Public Health, University of Alabama at Birmingham.
- Texas Biomed, San Antonio, Texas.
- Departments of Medicine and Public Health, NYU Grossman School of Medicine, New York, New York.
Förderung
- NHLBI NIH HHS
- NCRR NIH HHS
- NINDS NIH HHS
- NIDDK NIH HHS
- NIA NIH HHS
- NCATS NIH HHS
- Intramural NIH HHS
- NIH HHS
Zitieren
APA
Oelsner, E. C., Sun, Y., Balte, P. P., Allen, N. B., Andrews, H., Carson, A., Cole, S. A., Coresh, J., Couper, D., Cushman, M., Daviglus, M., Demmer, R. T., Elkind, M. S. V., Gallo, L. C., Gutierrez, J. D., Howard, V. J., Isasi, C. R., Judd, S. E., Kanaya, A. M., …, & Post, W. S. (2024). Epidemiologic Features of Recovery From SARS-CoV-2 Infection. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2024.17440
Vancouver
Oelsner EC, Sun Y, Balte PP, Allen NB, Andrews H, Carson A, et al. Epidemiologic Features of Recovery From SARS-CoV-2 Infection. JAMA Network Open. 2024. doi:10.1001/jamanetworkopen.2024.17440
BibTeX
@article{Oelsner2024,
author = {Oelsner, Elizabeth C and Sun, Yifei and Balte, Pallavi P and Allen, Norrina B and Andrews, Howard and Carson, April and Cole, Shelley A and Coresh, Josef and Couper, David and Cushman, Mary and Daviglus, Martha and Demmer, Ryan T and Elkind, Mitchell S V and Gallo, Linda C and Gutierrez, Jose D and Howard, Virginia J and Isasi, Carmen R and Judd, Suzanne E and Kanaya, Alka M and Kandula, Namratha R and Kaplan, Robert C and Kinney, Gregory L and Kucharska-Newton, Anna M and Lackland, Daniel T and Lee, Joyce S and Make, Barry J and Min, Yuan-I and Murabito, Joanne M and Norwood, Arnita F and Ortega, Victor E and Pettee Gabriel, Kelley and Psaty, Bruce M and Regan, Elizabeth A and Sotres-Alvarez, Daniela and Schwartz, David and Shikany, James M and Thyagarajan, Bharat and Tracy, Russell P and Umans, Jason G and Vasan, Ramachandran S and Wenzel, Sally E and Woodruff, Prescott G and Xanthakis, Vanessa and Zhang, Ying and Post, Wendy S},
title = {Epidemiologic Features of Recovery From SARS-CoV-2 Infection},
journal = {JAMA Network Open},
year = {2024},
doi = {10.1001/jamanetworkopen.2024.17440}
}
EUVIMED